Comparing Biologic Options in Chronic Spontaneous Urticaria

(MedPage Today) — As biologic options have expanded for the treatment of chronic spontaneous urticaria (CSU), the question of which one works best has gained importance.
The anti-immunoglobulin E (IgE) antibody omalizumab (Xolair) was first out…